ZIOPHARM Oncology, Inc.

343 articles about ZIOPHARM Oncology, Inc.

• ZIOPHARM Oncology, Inc. to Present at the 8th Annual Biotechnology Industry Organization (BIO) Investor Forum

  10/22/2009

• ZIOPHARM Oncology, Inc. Cancer Drug Shows Promise in Mid-Stage Trial

  10/14/2009

• ZIOPHARM Oncology, Inc. to Present at the 4th Annual JMP Healthcare Focus Conference

  9/30/2009

• ZIOPHARM Oncology, Inc. to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

  9/9/2009

• ZIOPHARM Oncology, Inc. Announces At Market Private Placement of $5.05 Million

  9/8/2009

• ZIOPHARM Oncology, Inc. to Present at the 8th Annual Needham Life Sciences Conference

  6/3/2009

• ZIOPHARM Oncology, Inc. Presents Positive Darinaparsin Clinical Data at American Society of Clinical Oncology's Prestigious Clinical Science Symposium

  6/1/2009

• ZIOPHARM Oncology, Inc. Reports First Quarter Financial Results

  5/15/2009

• ZIOPHARM Oncology, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results

  3/24/2009

• ZIOPHARM Oncology, Inc. Presents Positive Darinaparsin Phase II Data at American Society of Hematology Meeting

  12/8/2008

• Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum

  12/2/2008

• ZIOPHARM Oncology, Inc. Presents Positive Data from Studies of Palifosfamide

  11/17/2008

• ZIOPHARM Oncology, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

  11/5/2008

• ZIOPHARM Oncology, Inc. To Host Analyst & Institutional Investor Meeting

  11/3/2008

• ZIOPHARM Oncology, Inc. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference

  10/27/2008

• ZIOPHARM Oncology, Inc. Receives Orphan Medicinal Product Designation for Palifosfamide (ZIO-201) in the Treatment of Soft Tissue Sarcoma

  10/15/2008

• ZIOPHARM Oncology, Inc. To Present At Maxim Group Growth Investor Conference

  9/30/2008

• ZIOPHARM Oncology, Inc. To Present At The Third Annual JMP Securities Healthcare Focus Conference

  9/29/2008

• ZIOPHARM Oncology, Inc. to Present at UBS Warburg Global Life Sciences Conference

  9/18/2008

• ZIOPHARM Oncology, Inc. Commences Randomized Phase II Study of Palifosfamide in Soft Tissue Sarcoma

  9/5/2008